Jazz Pharmaceuticals, Azur Pharma combine
DUBLIN — Jazz Pharmaceuticals and Azur Pharma will become one company, the two drug makers said.
The two said the it now will be a specialty biopharmaceutical company called Jazz Pharmaceuticals plc and will be based in Dublin.
"As Jazz Pharmaceuticals plc, we are a growing, profitable specialty biopharmaceutical company with a diverse portfolio of products in the central nervous system and women's health areas," said Bruce Cozadd, chairman and CEO at Jazz Pharmaceuticals. "We now have a strengthened management team, a broader commercial organization and an efficient platform for further growth, with resources to build our product portfolio and a future pipeline."